Bluebird Bio Inc
(BLUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,305 | 221,755 | 113,006 | 161,160 | 260,629 |
| Marketable Securities | N/A | N/A | 67,321 | 138,343 | 419,599 |
| Receivables | 3,094 | 560 | 14,627 | 11,389 | 3,872 |
| Inventories | 65,017 | 22,919 | 0 | N/A | 10,698 |
| Other current assets | 13,618 | 21,651 | 0 | 0 | 495,021 |
| TOTAL | $154,668 | $281,685 | $203,572 | $336,520 | $1,215,537 |
| Non-Current Assets | |||||
| PPE Net | 60,848 | 65,936 | 67,636 | 9,706 | 17,373 |
| Investments And Advances | 0 | 0 | 1,414 | 97,114 | 61,445 |
| Intangibles | 15,193 | 16,084 | 10,514 | 5,646 | 10,043 |
| Other Non-Current Assets | 229,523 | 255,456 | 286,678 | 144,809 | 476,854 |
| TOTAL | $305,564 | $337,476 | $366,242 | $257,275 | $565,715 |
| Total Assets | $460,232 | $619,161 | $569,814 | $593,795 | $1,781,252 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 87,167 | 2,520 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 34,316 | 18,498 | 14,867 | 25,883 | 13,811 |
| Accrued Expenses | 85,975 | 73,188 | 53,464 | 103,958 | 98,190 |
| TOTAL | $321,462 | $200,113 | $156,579 | $152,993 | $203,588 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,796 | 37,732 | 69,682 | N/A | N/A |
| Other Non-Current Liabilities | 162,508 | 186,779 | 209,220 | 66,525 | 222,608 |
| TOTAL | $170,304 | $224,511 | $278,902 | $66,525 | $222,608 |
| Total Liabilities | $491,766 | $424,624 | $435,481 | $219,518 | $426,196 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,790 | 9,696 | 5,319 | 3,572 | 3,357 |
| Common Shares | 1,923 | 1,905 | 830 | 711 | 665 |
| Retained earnings | -4,501,043 | -4,260,328 | -4,048,415 | -3,719,925 | -2,900,547 |
| Other shareholders' equity | -2,133 | -1,796 | -4,070 | -2,911 | -5,505 |
| TOTAL | $-31,534 | $194,537 | $134,333 | $374,277 | $1,355,056 |
| Total Liabilities And Equity | $460,232 | $619,161 | $569,814 | $593,795 | $1,781,252 |